Dr. Sood is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Gynecologic Oncology, 1995 - 1996
- University of FloridaResidency, Obstetrics and Gynecology, 1991 - 1995
- University of North Carolina at Chapel Hill School of MedicineClass of 1991
Certifications & Licensure
- GA State Medical License 2023 - 2026
- TX State Medical License 2002 - 2026
- WA State Medical License 2023 - 2026
- AZ State Medical License 2023 - 2025
- FL State Medical License 1993 - 2025
- LA State Medical License 2023 - 2025
- MS State Medical License 2023 - 2025
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2007 Jan 01
- Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin Start of enrollment: 2008 Feb 01
- First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Start of enrollment: 2010 Apr 14
Publications & Presentations
PubMed
- 57 citationsPerioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and P...R. Haldar, Lee Shaashua, Hagar Lavon, Yasmin A. Lyons, Oded Zmora
Brain, Behavior, and Immunity. 2018-05-22 - 99 citationsNuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer CellsXue Pan, Thiruvengadam Arumugam, Tameyoshi Yamamoto, Pavel A. Levin, Vijaya Ramachandran
Clinical Cancer Research. 2008-12-15 - 1594 citationsPan-cancer analysis of whole genomesPeter J. Campbell, Gad Getz, Jan O. Korbel, Joshua M. Stuart, Jennifer L. Jennings
Nature. 2020-02-06
Journal Articles
- Minimally Invasive Surgery and Risk of Capsule Rupture for Women with Early-Stage Ovarian CancerKoji Matsuo, Lynda D Roman, Anil K Sood, JAMA Oncology
- Minimally Invasive Surgery and Risk of Capsule Rupture for Women with Early-Stage Ovarian CancerLynda D Roman, Anil K Sood, JAMA Oncology
- EGFL6 Promotes Breast Cancer by Simultaneously Enhancing Cancer Cell Metastasis and Stimulating Tumor AngiogenesisXuejun Fan, Anil K Sood, Nature
- Join now to see all
Authored Content
- Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple Negative Breast Cancer via SMAD2/3/4 and mTORC2 SignalingJuly 2018
Press Mentions
- Funda Meric-Bernstam, M.D., Elected to National Academy of MedicineOctober 21st, 2024
- Most Cancers of the Unknown Main Survivor: Why I Joined a Scientific Trial at MD AndersonSeptember 23rd, 2022
- Cancer of the Unknown Primary Survivor: Why I Joined a Clinical Trial at MD AndersonSeptember 23rd, 2022
- Join now to see all
Grant Support
- Ovarian Cancer: Mechanisms Of Neuroendocrine RegulationNational Cancer Institute2005–2012
- Training Of Academic Gynecologic OncologistsNational Cancer Institute2011
- New Reagents For Synthesis Of High Potency SirnaNational Institute Of General Medical Sciences2010–2011
- Ovarian Cancer PlateletsNational Center For Research Resources2010–2011
- Texas Center For Cancer NanomedicineNational Cancer Institute2010–2011
- P2 - Targeting Dii4-Notch Signaling In Ovarian CancerNational Cancer Institute2010–2011
- Nanotechnology Platforms For Targeting Ovarian Cancer VasculatureNational Cancer Institute2010–2011
- EPHA2 Targeting In Uterine CarcinomaNational Cancer Institute2010–2011
- Subcellular Localization Of NanoparticlesNational Institute Of General Medical Sciences2010
- Subcellular Localization Of NanoparticlesNational Institute Of General Medical Sciences2009–2010
- Cell-Specific Targeting Of Ovarian Cancer VasculatureNational Cancer Institute2008–2009
- Tumor Metastasis: Biobehavioral MechanismsNational Cancer Institute2004–2009
- Anorectal Manometry To Asscess Rectal Dysfunction Following HysterectomyNational Center For Research Resources1998–2000
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: